Currently, the standard of care does not include injecting or prescribing unapproved experimental peptides for injuries there is no FDA approval or authoritative guideline endorsing BPC-157 use
Protocols that already use Wolverine (BPC-157 + TB-500) and want to add a tissue-quality layer
The trial enrolled 338 participants across four dose groups plus placebo and ran for 48 weeks
The pharmacology is well described in the peer-reviewed literature, but clinical effect sizes vary by indication, dosing, individual factors, and adherence, which is a large part of why frequency cannot be generalized
Most commercial payers don't require NDC on professional CMS-1500 claims
Keep injecting, tolerate the symptoms, and eventually youll restore your B12 levels